Abstract: A method of forming a coating that includes depositing a multicomponent glass layer on a polymer substrate and depositing a heat absorbing layer on the multicomponent glass layer. Inducing spinodal decomposition of the multicomponent glass layer by annealing the heat absorbing layer, and etching at least one of a phase separated component of the multicomponent glass layer. The spinodal decomposition may be achieved through a pulse thermal or electromagnetic assisted annealing process. The coating may then be used as a hydrophilic surface, or may be fluorinated using conventional methods to produce the superhydrophobic coating.

Abstract: A thermochromic device includes a film and a number of vanadium dioxide nanowires disposed within the film. The film is manufactured by hot extruding a material that includes a polymer and a plurality of vanadium dioxide nanowires on a drum to form a rough film.

Abstract: An ultrasonic transmitter includes a piezoelectric integrated thin film transistor (PITFT). The transistor includes a top gate electrode, a bottom gate electrode, and a piezoelectric layer. The piezoelectric layer generates vibrations in response to a voltage applied across the top gate electrode and the bottom gate electrode. The transistor includes micro-electrical-mechanical systems (MEMS) mechanically coupled to the PITFT. The MEMS includes a resonator that transmits ultrasonic pressure waves based on the vibrations.

Abstract: A device and method of making such a device that includes a flexible OLED layer comprising a light emitting side and a self-oscillating layer disposed on the light emitting side of the flexible OLED layer. The self-oscillating layer comprises an elastic polymer matrix containing a photo-responsive element and independently self-oscillating gel islands. The photo-responsive element in the elastic polymer matrix causes synchronization of the independently self-oscillating polymer gel islands in response to light emitted from the flexible OLED layer.

Abstract: A quantum well device includes a first layer of a first two-dimensional material, a second layer of a second two-dimensional material, and a third layer of a third two-dimensional material disposed between the first layer and second layer. The first layer, the second layer, and the third layer are adhered predominantly by van der Waals force.

Abstract: A device for producing polarized light includes a plurality of photonic crystal grid structures on a substrate. The plurality of photonic crystal grid structures includes one or more structured regions for the transmission of polarized blue light, polarized green light, and polarized red light. A green quantum dot layer is substantially positioned on the one or more structured regions for the transmission of polarized green light and a red quantum dot layer is substantially positioned on the one or more structured regions for the transmission of polarized red light. A blue light emitting diode array is disposed on the polarized light device such that the emission from the blue light emitting diode array facilitates the emission of red and green light from the red and green quantum dot layers.

Abstract: A device and method of making such a device that includes a flexible OLED layer comprising a light emitting side and a self-oscillating layer disposed on the light emitting side of the flexible OLED layer. The self-oscillating layer comprises an elastic polymer matrix containing a photo-responsive element and independently self-oscillating gel islands. The photo-responsive element in the elastic polymer matrix causes synchronization of the independently self-oscillating polymer gel islands in response to light emitted from the flexible OLED layer.

Abstract: The present invention relates to a method for assaying soluble GPC3 protein in a test sample, comprising using two different antibodies binding to different epitopes present in the N-terminal region of GPC3 protein.

Abstract: A thermochromic device includes a film and a number of vanadium dioxide nanowires disposed within the film. Each of the number of vanadium dioxide nanowires may have an aspect ratio between 10 and 500. The vanadium dioxide nanowires may have a length between 1 micrometer and 10 micrometers. The vanadium dioxide nanowires may have a non-conducting to conductor phase change temperature between 20 degrees Celsius and 60 degrees Celsius.

Abstract: A method of forming a coating that includes depositing a multicomponent glass layer on a polymer substrate and depositing a heat absorbing layer on the multicomponent glass layer. Inducing spinodal decomposition of the multicomponent glass layer by annealing the heat absorbing layer, and etching at least one of a phase separated component of the multicomponent glass layer. The spinodal decomposition may be achieved through a pulse thermal or electromagnetic assisted annealing process. The coating may then be used as a hydrophilic surface, or may be fluorinated using conventional methods to produce the superhydrophobic coating.

Abstract: An ultrasonic transmitter includes a piezoelectric integrated thin film transistor (PITFT). The transistor includes a top gate electrode, a bottom gate electrode, and a piezoelectric layer. The piezoelectric layer generates vibrations in response to a voltage applied across the top gate electrode and the bottom gate electrode. The transistor includes micro-electrical-mechanical systems (MEMS) mechanically coupled to the PITFT. The MEMS includes a resonator that transmits ultrasonic pressure waves based on the vibrations.

Abstract: A method of detecting a defect in a barrier film. The method includes: coating the barrier film with a solution having a plurality of probes, where each of the probes has a nanoparticle; forcing a probe of the plurality of probes to penetrate the defect by applying a field to the barrier film, where the field induces an attractive power to the nanoparticles of the probes; applying an optical excitation (OE) to the barrier film; and identifying the defect in the barrier film based on an optical signal emitted, in response to the OE, by the probe forced to penetrate the defect.

Abstract: The present invention discloses a method for determining the efficacy of GPC3-targeting drug therapy for cancer in a patient before the start of GPC3-targeting drug therapy or a patient or determining the continuation of GPC3-targeting drug therapy for a patient, including monitoring a concentration of free GPC3 in a biological sample isolated from the patient before the start of GPC3-targeting drug therapy and/or the patient treated with the GPC3-targeting drug therapy, wherein when the concentration of free GPC3 is a predetermined value, the efficacy of the GPC3-targeting drug therapy is determined or the continuation of the GPC3-targeting drug therapy is determined. The present invention also discloses a GPC3-targeting drug or a preparation which is to be further administered to a patient for which the efficacy of the GPC3-targeting drug therapy has been determined or the continuation of the GPC3-targeting drug therapy has been determined.

Abstract: A method that includes coating a photopolymer layer on a substrate to create a photopolymer coating, passing light from a light source through an aperture array to create a light interference pattern, and exposing the photopolymer coating to the light interference pattern to create cross-linked regions and non-cross-linked regions within the photopolymer coating. The method further includes creating a thermal insulation film product by dissolving the non-cross-linked regions to create a porous thermal insulation film disposed on the substrate.

Abstract: An object of the present invention is to provide a method of efficiently constructing a gene delivery carrier having a favorable activity and expression efficiency of a protein expressed by a gene introduced by transformation. Moreover, an object of the present invention is to provide a pharmaceutical composition comprising a gene delivery carrier constructed by the construction method and a therapeutic agent for solid tumor comprising the resistant bacterium.

Abstract: The present invention provides a method for producing a cytosine deaminase (CD)-expressing, 5-fluorouracil (5-FU)-resistant microorganism which can grow in anaerobic tumor tissues, can express CD, and has a resistance to 5-FU at a concentration that is at least effective for antitumor activity. More specifically, the method is a method (A) comprising performing subculture or acclimation culture of a CD-expressing microorganism which can grow in anaerobic tumor tissues, in the presence of 5-fluorocytosine (5-FC), or a method (B) comprising (1) performing subculture or acclimation culture of a microorganism which can grow in anaerobic tumor tissues and does not express CD, in the presence of 5-FU to produce a 5-FU-resistant microorganism and (2) transforming the 5-FU-resistant microorganism by introducing a CD gene. The present invention also provides the CD-expressing, 5-FU-resistant microorganism and a pharmaceutical composition comprising the microorganism.

Abstract: A pharmaceutical preparation comprising a hepatocyte growth factor or a DNA molecule encoding the same and the like according to the present invention can suppress the fibrosis of a transplanted organ after organ transplantation. The present invention is useful in the fields of organ transplantation and regeneration therapy.

Abstract: A pharmaceutical preparation comprising a hepatocyte growth factor or a DNA molecule encoding the same and the like according to the present invention can suppress the fibrosis of a transplanted organ after organ transplantation. The present invention is useful in the fields of organ transplantation and regeneration therapy.

Abstract: A pharmaceutical preparation comprising a hepatocyte growth factor or a DNA molecule encoding the same and the like according to the present invention can suppress the fibrosis of a transplanted organ after organ transplantation. The present invention is useful in the fields of organ transplantation and regeneration therapy.

Abstract: The present invention provides a shuttle vector for a microorganism of the genus Bifidobacterium (BM) and Escherichia coli having a wide host range and a large copy number in BM and capable of highly expressing a desired protein when used as an expression vector; an expression vector capable of expressing a desired gene in BM by use of the shuttle vector; BM transformed with the expression vector; and an antitumor agent comprising the BM as an active ingredient. It comprises a pTB6-derived region portion comprising a replication origin (oriV)-repB region of pTB6 but not comprising MembB, MobA, OrfI, and oriT regions of pTB6 and an Escherichia coli-derived plasmid portion comprising a replication origin (Puc Ori) region of Escherichia coli but having deleted DNA encoding an N-terminal region of an ampicillin resistance gene (ampR) expression product ?-lactamase.